US Pre-Market SEC Filings Roundup — October 27, 2026

26-10-2026

Teleios Capital Partners GmbH, its Cayman master fund Teleios Global Opportunities Master Fund, Ltd., and managing member Igor Kuzniar filed Amendment No. 2 to Schedule 13D disclosing beneficial ownership of 4,022,113 shares of Quanex Building Products (NX), or 8.78% of 45,826,208 shares outstanding. The filing reports open-market sales of 229,766 shares between October 22 and October 26, 2026 at weighted average prices of $19.59 to $20.66, and that the board observer seat was terminated.

• · The Reporting Persons received their shares in the 2024 Tyman plc acquisition by exchanging Tyman shares for Quanex voting securities
• · The Reporting Persons' board observer seat under a Board Observer Agreement has terminated, and they no longer hold observer rights
• · The Reporting Persons have engaged in dialogue with management and the board on capital allocation, strategy, and governance to enhance shareholder value
• · All reported transactions were open-market sales; the filing notes the reporting persons will provide per-price detail to the SEC on request

26-10-2026

Director Eagle Equity Partners IV, LLC exercised/converted 5,159,999 Class A Ordinary Shares. Eagle Equity Partners IV, LLC holds 5,517,999 shares after the transaction.

• · Director Eagle Equity Partners IV, LLC exercised/converted 5,159,999 Class A Ordinary Shares
• · Director Eagle Equity Partners IV, LLC exercised/converted 5,159,999 Class B Ordinary Shares

26-10-2026

Director RAIKES JEFFREY S was awarded 266 Common Stock. RAIKES JEFFREY S holds 6,309.936 shares after the transaction.

• · Director RAIKES JEFFREY S was awarded 266 Common Stock

26-10-2026

CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought 5,880 CTTH at $0.06 (~$335). CTT PHARMACEUTICAL HOLDINGS, INC. holds 9,442,536 shares after the transaction.

• · CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought 5,880 CTTH at $0.06 (~$335)

26-10-2026

10% owner Conifer Management, L.L.C. bought 18,920 Common Stock at $242.77 (~$4.59M). 30 transactions reported in total. Conifer Management, L.L.C. holds 2,012,290 shares after the transaction.

• · 10% owner Conifer Management, L.L.C. bought 120 Common Stock at $226.00 (~$27.1K)
• · 10% owner Conifer Management, L.L.C. bought 1 Common Stock at $228.24 (~$228)
• · 10% owner Conifer Management, L.L.C. bought 164 Common Stock at $230.97 (~$37.9K)
• · 10% owner Conifer Management, L.L.C. bought 160 Common Stock at $232.28 (~$37.2K)
• · 10% owner Conifer Management, L.L.C. bought 120 Common Stock at $233.76 (~$28.1K)
• · 10% owner Conifer Management, L.L.C. bought 563 Common Stock at $235.50 (~$133K)
• · 10% owner Conifer Management, L.L.C. bought 9,501 Common Stock at $236.02 (~$2.24M)
• · 10% owner Conifer Management, L.L.C. bought 1,907 Common Stock at $237.43 (~$453K)

26-10-2026

Chief Executive Officer Tsang Chi Keung had withheld for taxes 1,294 Common Stock at $26.43 (~$34.2K). 17 transactions reported in total. Tsang Chi Keung holds 7,950 shares after the transaction.

• · Chief Executive Officer Tsang Chi Keung was awarded 4,186 Common Stock
• · Chief Executive Officer Tsang Chi Keung had withheld for taxes 1,496 Common Stock at $20.17 (~$30.2K)
• · Chief Executive Officer Tsang Chi Keung exercised/converted 142 Common Stock
• · Chief Executive Officer Tsang Chi Keung exercised/converted 3,776 Common Stock
• · Chief Executive Officer Tsang Chi Keung had withheld for taxes 1,272 Common Stock at $13.31 (~$16.9K)
• · Chief Executive Officer Tsang Chi Keung exercised/converted 142 Common Stock
• · Chief Executive Officer Tsang Chi Keung exercised/converted 3,776 Common Stock
• · Chief Executive Officer Tsang Chi Keung had withheld for taxes 1,294 Common Stock at $26.43 (~$34.2K)

26-10-2026

Chief Legal Counsel Zimmermann Curtis J. was awarded 308,608 Stock Option (right to buy). 8 transactions reported in total.

• · Chief Legal Counsel Zimmermann Curtis J. was awarded 308,608 Stock Option (right to buy)
• · Chief Legal Counsel Zimmermann Curtis J. was awarded 26,358 Stock Option (right to buy)
• · Chief Legal Counsel Zimmermann Curtis J. was awarded 19,946 Stock Option (right to buy)
• · Chief Legal Counsel Zimmermann Curtis J. was awarded 170,603 Stock Option (right to buy)
• · Chief Legal Counsel Zimmermann Curtis J. was awarded 12,823 Stock Option (right to buy)
• · Chief Legal Counsel Zimmermann Curtis J. was awarded 25,361 Stock Option (right to buy)
• · Chief Legal Counsel Zimmermann Curtis J. was awarded 321,601 Performance Stock Units
• · Chief Legal Counsel Zimmermann Curtis J. was awarded 101,176 Performance Stock Units

26-10-2026

Director Lai Jimmy Y. exercised/converted 23,505 Class A Ordinary Share, par value US$0.0001. Lai Jimmy Y. holds 3,005,741 shares after the transaction.

• · Director Lai Jimmy Y. exercised/converted 23,505 Class A Ordinary Share, par value US$0.0001
• · Director Lai Jimmy Y. was awarded 94,020 Restricted Share Units (RSUs)
• · Director Lai Jimmy Y. exercised/converted 23,505 Restricted Share Units (RSUs)

26-10-2026

Antalpha Capital (HK) Limited and its parent Antalpha Platform Holding Company filed Amendment No. 1 to Schedule 13D on Aurelion Inc. (formerly Prestige Wealth Inc., Nasdaq: AURE) disclosing a share subscription agreement dated October 22, 2026 to buy 952,381 Class B Ordinary Shares at US$2.1 per share for US$2,000,000, with closing expected October 29, 2026 or another agreed date. On a fully diluted basis the reporting persons would hold about 49.1% of the Class A class (24,841,271 shares), which, given 50-vote Class B shares, strengthens their existing controlling voting position. The filing does not report period-over-period financial results, so no growth or decline metrics are available.

• · The Subscription has not closed as of the amendment date; closing is expected October 29, 2026 and is subject to customary conditions, including the absence of a continuing Material Adverse Effect and no Nasdaq objection to the additional-share listing notification
• · Proceeds are to be used by the Issuer for working capital and operating expenses
• · The reporting persons' beneficial ownership figure assumes full exercise of warrants, closing of the Subscription, and one-to-one conversion of all Class B shares, so it is a fully diluted estimate
• · Required Shareholder Approval for the warrant exercise was obtained at meetings convened November 20, 2025
• · The source of funds was a capital contribution from Antalpha Platform Holding Company, which passed a unanimous board resolution authorizing the Subscription Agreement
• · The filing describes the Subscription as intended to strengthen the reporting persons' existing controlling voting position

26-10-2026

Director Whitney Meredith bought 1,000 Common Shares of Beneficial Interest at $23.49 (~$23.5K). Whitney Meredith holds 1,000 shares after the transaction.

• · Director Whitney Meredith bought 1,000 Common Shares of Beneficial Interest at $23.49 (~$23.5K)

26-10-2026

Director Whitney Meredith bought 1,500 Common Shares of Beneficial Interest at $17.75 (~$26.6K). Whitney Meredith holds 1,500 shares after the transaction.

• · Director Whitney Meredith bought 1,500 Common Shares of Beneficial Interest at $17.75 (~$26.6K)

26-10-2026

Director Lindsay Mark F. was awarded 12,000 Stock Options (Right to Buy).

• · Director Lindsay Mark F. was awarded 12,000 Stock Options (Right to Buy)

26-10-2026

President, Network Solutions Linetsky David bought 35 Common Stock at $10.35 (~$362). Linetsky David holds 22,197 shares after the transaction.

• · President, Network Solutions Linetsky David bought 35 Common Stock at $9.15 (~$320)
• · President, Network Solutions Linetsky David bought 35 Common Stock at $10.35 (~$362)

23-10-2026

Power REIT's Board is soliciting shareholder votes for its October 27, 2026 Annual Meeting, where approval of Proposal 3 (allowing Series A Preferred holders, voting as a separate class, to amend the Series A Articles Supplementary) requires a majority of all 367,120 outstanding Common Shares. As of October 22, 2026, only about 37% of outstanding Common Shares had voted in favor, so the proposal remains well short of the threshold, and non-votes effectively count against it. ISS has recommended a vote FOR, and the Board may adjourn the meeting if sufficient votes are not obtained.

• · Record date for voting was September 11, 2026
• · Annual Meeting scheduled for October 27, 2026 at 10:30 a.m. Eastern at 477 Madison Avenue, New York, NY
• · Board believes approval preserves capital structure flexibility, may help preserve NYSE American listing and capital-raising ability, and avoids a second common shareholder vote
• · Proxy statement risks flagged for shareholders include potential dilution
• · Broker non-votes cannot be cast on Proposal 3 without explicit shareholder instructions
• · Proxies already submitted remain valid if the meeting is adjourned; record date will not change

27-10-2026

ORIX Corporation filed a 6-K disclosing the disposal of 81,040 shares of its common stock to 355 offerees, comprising 240 employees of the Company, 112 employees of its subsidiaries, and 3 directors of its subsidiaries, at a disposal price of 5,732 yen per share. The total value of shares to be disposed is 464,521,280 yen, with no amount incorporated into capital. The filing is a routine employee share-allocation style disclosure with no stated negative or flat performance metrics.

• · Breakdown of shares: 56,280 shares to Company employees, 23,980 shares to subsidiary employees, and 780 shares to subsidiary directors
• · Amount incorporated into capital is nil
• · Disclosure references Article 2-12, Paragraph 1, Item (i) of the Cabinet Order for Enforcement of the Financial Instruments and Exchange Act regarding subsidiary directors as offerees

27-10-2026

HUTCHMED (China) Limited furnished a Form 6-K for October 2026 attaching Exhibit 99.1, a press release announcing that the company will host an expert insights event on recent savolitinib clinical data in non-small cell lung cancer. The filing itself contains no financial results, monetary amounts, or quantitative performance metrics.

• · Filing is a Form 6-K (Foreign Issuer Report) for the month of October 2026, with the press release provided as Exhibit 99.1
• · Filing signed by Johnny Cheng, Chief Financial Officer, dated October 27, 2026

27-10-2026

Novartis AG furnished a Form 6-K dated October 27, 2026, attaching its Financial Report for Q3 2026 (Exhibit 99.1) and a Condensed Financial Report (Exhibit 99.2). The filing itself is a cover document with exhibits incorporated by reference; the specific revenue, earnings, and segment figures are contained in the exhibits, which were not included in the provided text, so no quantitative results can be verified from this content.

• · Exhibit 99.1 is the Financial Report for Q3 2026, including an R&D update with key developments from the first quarter, incorporated by reference into Form S-8 registration statements
• · Exhibit 99.2 is a Condensed Financial Report furnished with the filing
• · The registrant is a foreign private issuer that files annual reports on Form 20-F

27-10-2026

Amendment No. 6 to Schedule 13D filed by Chutzpah Holdings Limited (CHL), Chutzpah Holdings LP (CHLP), Plantae Bioscience Ltd. and Alexandre Weinstein discloses CHLP's acquisition of 833,334 Pluri Inc. common shares at $1.50 per share under an October 20, 2026 Securities Purchase Agreement, settled by applying a $1,250,000 advance made under a June 14, 2026 Advance Subscription Agreement. The aggregate reporting group now beneficially owns 4,561,616 shares, or approximately 38.85% of outstanding common stock, above the 35% beneficial ownership limitation that blocks exercise of 625,000 March 2026 CHLP warrants. The October 2026 warrants (833,334 shares at $1.65) are excluded because they are not exercisable within 60 days.

• · Reporting group ownership crossed the 35% Beneficial Ownership Limitation, blocking exercise of 625,000 March 2026 CHLP warrants
• · October 2026 shares were acquired at $1.50 per share, well below the $4.00 CHLP paid in December 2025 and March 2026 and the $4.61 price in the January 2025 SPA
• · The $1.25M purchase was settled from a prior advance rather than new cash, per the June 14, 2026 Advance Subscription Agreement
• · The filing states it is primarily for disclosing the October 2026 acquisition; a reported 'fifth amendment' date of [July 1], 2026 contains an unfilled bracket placeholder
• · Weinstein's 4,561,616 share figure includes 641 RSUs vesting November 25, 2026, and excludes 3,203 unvested RSUs

27-10-2026

Aclaris Therapeutics announced positive primary analysis results from two Phase 1b proof-of-concept trials of its anti-TSLP/IL-4Rα bispecific antibody ATI-052 in atopic dermatitis (AD) and asthma, with a favorable safety profile and no conjunctivitis observed. The company will prioritize a Phase 2b trial in eosinophilic esophagitis (EoE) early next year, with an update on a potential additional indication expected in the near term. Results are based on small trials (14 AD patients, 16 asthma patients), with the AD per-protocol analysis excluding four patients and asthma subgroup data being post hoc.

• · Four AD patients were excluded from the per-protocol analysis for reasons defined before unblinding: two in the ATI-052 arm (only two doses taken; eligibility criteria not met) and two in the placebo arm (early rescue medication)
• · The asthma FEV1 subgroup result (350 ml improvement) is a post hoc analysis, not a prespecified endpoint
• · No Grade 3 or 4 TEAEs were observed and no adverse events led to study discontinuation; injection site reactions were transient and almost exclusively Grade 1
• · AD response durability at week 16 is based only on patients with available data, with follow-up ongoing
• · Company plans to provide an update on a potential additional indication in the near term
• · ATI-052 engineered to bind FcRn more tightly to extend half-life; exclusive worldwide rights excluding Greater China

27-10-2026

Hycroft Mining reported Q3 2026 results and the filing of its Form 10-Q, highlighting $211 million in unrestricted cash with no debt, a 2025-2026 exploration drill program of approximately 18,700 meters drilled, and continued high-grade silver results at Brimstone and Vortex. The company announced leadership changes, including Michael Deal's appointment as Chief Operating Officer, the planned transition of CFO Stan Rideout to Executive Vice President, Strategic Advisor effective March 16, 2027 (with a CFO search underway), and the retirement of David Thomas effective April 30, 2027. The filing contains no revenue, earnings, or period-over-period financial comparison data, and no negative operating metrics are disclosed.

• · CFO Stan Rideout transitions to Executive Vice President, Strategic Advisor effective March 16, 2027; a CFO search has commenced
• · David Thomas retires effective April 30, 2027 and will remain a consultant
• · Four new independent directors appointed to the Board, covering mining operations, technical services, finance, and governance
• · Conceptual underground mine design work with RESPEC and Hatch is substantially complete and will feed 2027 project optimization
• · Roasting vs. POX processing trade-off study to be finalized in Q4 2026, with results expected in Q1 2027
• · Heap leach metallurgical test work expected to complete in the first half of 2027

27-10-2026

UPS reported third-quarter 2026 consolidated revenue of $22.9B, up 6.7%, with growth across all segments, GAAP diluted EPS of $1.37 and non-GAAP adjusted diluted EPS of $1.69. GAAP results absorbed a $279M net charge ($0.32 per diluted share), including a $182M goodwill impairment in Supply Chain Solutions, while U.S. Domestic operating margin of 6.1% (7.0% adjusted) and total GAAP operating profit of $1.7B compare with prior-year levels that included a $330M sale-leaseback gain. Management raised full-year 2026 guidance for revenue, adjusted operating profit, adjusted EPS and adjusted free cash flow.

• · Supply Chain Solutions GAAP operating margin fell to 3.1% and adjusted margin to 9.2%, with segment operating profit well below Q3 2025 levels despite 18.2% revenue growth.
• · Prior-year Q3 2025 results included a $330M pre-tax sale-leaseback gain ($0.30 EPS) in Supply Chain Solutions, which flatters year-over-year comparisons.
• · U.S. Domestic GAAP operating margin of 6.1% reflects transformation-related costs; the adjusted margin of 7.0% excludes these charges.
• · Full-year 2026 transformation costs excluded from adjusted results are expected at $1.4B-$1.6B, and the Efficiency Reimagined initiative is not expected to conclude until Q4 2027.
• · Planned volume reductions from UPS's largest customer were completed in Q2 2026, following the expansion of network reconfiguration that began in Q4 2024.
• · Q3 GAAP results include an MD-11 aircraft-related gain of $33M, arising from sales of previously impaired parts recognized in 2026.

27-10-2026

Imunon, Inc. (Nasdaq: IMNN) furnished an investor presentation dated October 2026 on October 26, 2026, which the company expects to use in investor calls and/or conferences. The filing is a procedural 8-K under Item 8.01 (Other Events) with the presentation attached as Exhibit 99.1; it contains no financial results, quantitative disclosures, or new operational announcements in the body of the filing itself.

• · Filing covers an event date of October 26, 2026 and was dated October 27, 2026 per the filing metadata.
• · Securities registered under Section 12(b): common stock, par value $0.01 per share, ticker IMNN, Nasdaq Capital Market.
• · Company is headquartered at 997 Lenox Drive, Suite 100, Lawrenceville, NJ; Commission File Number 001-15911.
• · Exhibit 99.1 (Investor Presentation) and Exhibit 104 (Cover Page Interactive Data File) are furnished with the filing; the presentation's contents are not reproduced in the body text provided.

27-10-2026

Equinor ASA disclosed transactions under the third tranche of its 2026 share buy-back programme for the period 19 to 22 October 2026. Over four trading days, the company repurchased 518,500 shares on the Oslo Stock Exchange (OSE) at a volume-weighted average price of NOK 435.0082, for a total transaction value of NOK 225,551,742.20. Cumulative buy-backs under the tranche now total 8,756,607 shares for NOK 3,507,806,474.39 at an average price of NOK 400.5897.

• · Trading venues referenced include OSE, CEUX, and TQEX, but all reported volume occurred on OSE
• · Average daily repurchase volume during the period was approximately 129,600 shares
• · Weighted average price for the 19-22 October period (NOK 435.01) was above the cumulative tranche average (NOK 400.59), indicating recent purchases at higher prices

27-10-2026

ING Groep N.V. filed a Form 6-K on October 27, 2026, furnishing a press release dated the same day as Exhibit 99.1, which is incorporated by reference. The filing body contains no financial figures, named initiatives, or substantive disclosures; the press release content is not included in the provided text. The filing is signed by Raymond Vermeulen, Head of Media Relations & Issue Management.

27-10-2026

Arlo Technologies, Inc. (NYSE: ARLO) announced on October 27, 2026 that its Board of Directors authorized a share repurchase program of up to $100 million of its common stock through the end of 2028. The authorization is disclosed under Item 8.01 (Other Events) with the press release furnished as Exhibit 99.1. The filing contains no financial results, period-over-period comparisons, or performance metrics.

• · Filing is signed by CFO and COO Kurtis Binder and includes Exhibit 99.1 press release and Inline XBRL cover page data
• · Common stock trades on the New York Stock Exchange under symbol ARLO
• · Company headquarters listed at 5770 Fleet Street, Carlsbad, California

27-10-2026

HSBC USA Inc. (CIK 0000083246) reported third-quarter 2026 net income of $310 million, down 18% from $378 million a year earlier, while nine-month net income rose 20% to $991 million from $827 million. Net interest income was essentially flat at $528 million (up 1%) for the quarter, while total other revenues rose 6% to $579 million, led by trading revenue, which grew 49% to $278 million. However, comprehensive income fell 77% to $115 million for the quarter due to a $195 million other comprehensive loss, and total assets declined 1% from December 31, 2025 to $169,977 million.

• · Q3 2026 dividends declared on common stock were nil versus $500 million in Q3 2025; nine-month common dividends fell to $300 million from $1,500 million
• · Q3 2026 other comprehensive loss of $195 million was driven by a $408 million net unrealized loss on investment securities, partially offset by a $198 million gain on cash flow hedges
• · Nine-month 2026 operating cash flow was a net outflow of $9,036 million, driven by a $9,964 million increase in net trading assets and liabilities
• · Cash and interbank deposits fell to $13,813 million at September 30, 2026 from $25,094 million a year earlier
• · Q3 2026 loss on instruments designated at fair value and related derivatives widened to $50 million from $3 million
• · Q3 2026 provision for credit losses was a $21 million release versus an $84 million release in Q3 2025
• · Total common equity rose 3.5% from December 31, 2025 to $12,596 million, supported by retained earnings growth to $1,535 million from $852 million

27-10-2026

CenterPoint Energy reported Q3 2026 net income of $331M ($0.50 diluted EPS) versus $293M ($0.45) in Q3 2025, a 13% increase, driven by operating income rising 33% to $667M. Year-to-date, net income grew 13% to $891M, but results were mixed: the company recorded an $85M loss on equity securities and a $764M interest expense burden (up 15%), and the quarter's tax expense of $82M compared with a $7M benefit a year earlier. Total assets reached $49,475M, up from $46,534M at year-end 2025.

• · Nine-month operating income rose 19% to $1,859M, while net income growth of 13% was held back by a swing to an $85M loss on equity securities (versus an $18M gain) and higher interest expense of $764M (up from $663M).
• · Q3 2026 income tax expense was $82M versus a $7M benefit in Q3 2025, a major headwind to net income growth despite higher pre-tax income of $413M (up 44%).
• · Depreciation and amortization rose 17% YoY for nine months to $1,312M, reflecting continued capital investment, and Q3 D&A increased 13% to $444M.
• · Net property, plant and equipment grew to $36,420M from $34,056M at year-end 2025 (up 7%), while total gross PP&E reached $47,619M.
• · Current assets held for sale remain significant at $2,639M, tied to pending divestitures including the Ohio (CEOH) and Louisiana/Mississippi (LAMS) gas businesses.
• · Q3 2026 indexed debt securities produced a $24M loss, reversing a $105M gain in Q3 2025, and the nine-month figure is a gain of $80M compared with a $16M loss a year earlier.
• · Cash and cash equivalents rose to $132M from $38M, with $128M held by VIEs (securitization entities), up from $34M.
• · Investment in equity securities declined to $425M from $510M at year-end 2025, consistent with the reported equity securities losses.

27-10-2026

Cizzle Brands Corporation filed a Form 6-K on October 27, 2026, furnishing a press release dated October 26, 2026 (Exhibit 99.1) that it had previously filed with Canadian securities regulators via SEDAR+. The filing itself contains no financial results, quantitative metrics, or substantive business details; its content is limited to a cover reference to the attached press release, signed by CEO John Celenza.

• · Press release (Exhibit 99.1) dated October 26, 2026 was previously filed with Canadian Securities Regulatory Authorities via SEDAR+
• · Registrant is a foreign private issuer reporting on Form 40-F (Form 20-F box unchecked)
• · Principal executive office: 35 McCleary Court, Unit 21, Concord, Ontario L4K 3Y9, Canada
• · Report covers the month of October 2026; Commission File Number 333-298427

27-10-2026

Woodside Energy Group Ltd furnished a 6-K on October 27, 2026 attaching an ASX announcement titled "Woodside agrees Greater Sunrise sale to Timor Gap," indicating an agreement to sell its Greater Sunrise interest to Timor Gap. The filing body itself contains only the cover page, exhibit index, and signature block, so no transaction price, consideration, or financial terms are disclosed in the text provided.

• · Filing is a Form 6-K (Foreign Private Issuer report) for the month of October 2026, Commission File No. 001-41404
• · Attached Exhibit 99.1 is the ASX announcement dated October 27, 2026
• · Woodside is a Form 20-F filer and reports under Regulation S-T as a foreign private issuer

27-10-2026

Independent Bank Corporation (NASDAQ: IBCP) reported Q3 2026 net income of $17.9 million, or $0.80 per diluted share, versus $17.5 million, or $0.84 per diluted share, in the prior-year period, a slight decline in per-share earnings. Adjusted net income excluding after-tax merger-related expenses was $20.6 million, or $0.92 per diluted share. Net interest margin expanded to 3.79% and total assets rose to $6.26 billion following the July 1, 2026 acquisition of HCB Financial Corp. and Highpoint Community Bank, while provision for credit losses rose to $4.81 million and non-performing loans increased to $39.2 million.

• · Non-performing loans rose primarily in commercial loans, from $13.8 million to $37.6 million year over year, driven by four commercial relationships placed on non-accrual status
• · Q3 2026 net income includes $3.4 million in favorable mortgage servicing rights fair value changes ($0.12 per diluted share), versus a $0.6 million unfavorable change a year earlier
• · Expected Highpoint Community Bank full system integration on November 9, 2026
• · Q3 2026 dividend of $0.28 per share paid August 14, 2026
• · Tangible book value per share declined to $23.10 from $24.24, reflecting $39.1 million of goodwill and intangibles from the HCB acquisition
• · Earnings call scheduled for October 27, 2026 at 11:00 am ET

27-10-2026

Valion Bio, Inc. (Nasdaq: VBIO) disclosed that on October 26, 2026 it closed a Series B preferred stock tranche with 3i, LP, issuing 50 Series B Preferred Shares and warrants for 1,539 common shares at $1.0092 for $50,000. It also issued 4,717.73 Series C Preferred Shares and warrants for 2,524,343 common shares at $1.0092 to Series C purchasers, for an aggregate price of $4,717,717.61, of which $3,217,717.61 was retained to satisfy overdue cash true-up payments and $1,500,000 was paid in cash. The filing indicates the Series C true-up payments were overdue, and the cash component is small relative to the $75,000,000 Series C program, so the financing outcome is mixed.

• · Series B and Series C warrant exercise price of $1.0092 per share, with issuance under Section 4(a)(2) and/or Rule 506(b)
• · Series C Side Letter consideration partly consisted of retaining $3,217,717.61 to cover overdue cash true-up payments under Section 6(b) of the Series C Certificate of Designation
• · Exhibit 10.1 (Fourth 3i Side Letter) and Exhibit 10.2 (Series C Side Letter) are incorporated by reference
• · Company is an emerging growth company

27-10-2026

Nomura Holdings reported capital adequacy metrics as of June 30, 2026, with a common equity Tier 1 capital ratio of 13.20%, a Tier 1 capital ratio of 15.03%, and a consolidated capital adequacy ratio of 15.99%. Total risk-weighted assets stood at ¥25,015.3 Billion, and the consolidated leverage ratio was 4.77%. The filing provides no prior-period comparison, so the direction of change cannot be assessed from this document alone.

• · External TLAC ratio is 29.97% on a risk-weighted assets basis and 10.52% on a leverage ratio exposure measure basis
• · Risk-weighted assets are split as credit risk ¥14700.0 Billion, market risk ¥6113.3 Billion and operational risk ¥4201.9 Billion
• · No prior-period figures are provided, so period-over-period changes cannot be determined from this filing

27-10-2026

ioneer Ltd filed a Form 6-K on October 27, 2026 furnishing its Quarterly Report for the three months ended September 30, 2026 as Exhibit 99.1. The filing itself is a cover document that incorporates the press release by reference into ioneer's Form S-8 and Form F-3 registration statements; the excerpt provided does not contain the quarterly figures, so no financial performance metrics can be assessed from this content.

• · Commission File Number 001-41412; registrant files annual reports on Form 20-F (not 40-F)
• · Exhibit 99.1 covers the quarterly period ended September 30, 2026, and its contents are not included in the provided text
• · Exhibit 99.1 is incorporated by reference into Form S-8 (File No. 333-266137) and Form F-3 (File No. 333-297577)

27-10-2026

Hilton reported Q3 2026 diluted EPS of $2.37 (adjusted $2.45) and net income of $536 million, up from $421 million a year earlier, with system-wide comparable RevPAR up 5.8% on a currency-neutral basis. Results were strong, though management noted that Q4 RevPAR is guided to a slower 3.0%-3.5% increase, with Middle East pressure and timeshare license fees weighing on full-year Adjusted EBITDA guidance, which was lowered versus prior guidance. Hilton also reaffirmed roughly $3.5 billion in planned capital return for 2026 and announced a Nasdaq listing transfer effective November 5, 2026.

• · Q4 2026 RevPAR guidance (3.0%-3.5%) implies deceleration from Q3's 5.8%, citing midterm elections and increased Middle East impact
• · Full-year Adjusted EBITDA guidance was reduced relative to prior guidance due to lower Middle East expectations and timeshare license fees
• · Q3 RevPAR benefited from the World Cup and favorable calendar and holiday shifts, which are non-recurring tailwinds
• · $600 million of Senior Notes mature April 2027; management expects to address them at or before maturity
• · Net unit growth is expected near the midpoint of the 6.0%-7.0% range, with sequential growth in net additional rooms expected in Q4
• · Hilton is listing on Nasdaq under the unchanged HLT ticker effective November 5, 2026; no shareholder action is required
• · Q4 2026 guidance: diluted EPS $2.25-$2.31, net income $508M-$522M, Adjusted EBITDA $1,047M-$1,067M

27-10-2026

Atour Lifestyle Holdings Limited furnished a Form 6-K (Exhibit 99.1) announcing that it will report its third quarter 2026 financial results on November 10, 2026. The filing itself contains no financial figures, so no performance metrics can be assessed from this document.

• · Third quarter 2026 financial results release scheduled for November 10, 2026
• · Filing is a Form 6-K for the month of October 2026, signed October 27, 2026
• · Company headquartered at 618 Wuzhong Road, Minhang District, Shanghai, PRC; NYSE/SEC file number 001-40540

27-10-2026

INVESTMENT ADVISORY SERVICES INC /TX /ADV (The Woodlands, TX) filed a Form 13F-HR for the period ended September 30, 2026, reporting 135 holdings with an aggregate reported market value of approximately $355.1 billion. The portfolio is concentrated in large-cap technology and ETF positions, led by Apple, Microsoft, and Invesco QQQ, with the single largest line items being Apple at $15.66 billion and Microsoft at $18.63 billion. This is a routine quarterly institutional holdings disclosure with no reported share-count changes presented as trades in this document.

• · Filer is headquartered at 9303 New Trails Dr., Suite 450, The Woodlands, TX 77381; SEC file number 028-21110; report period ended September 30, 2026
• · Portfolio is heavily weighted toward ETFs and index-style vehicles, with many positions held as sole investment discretion
• · Ring Energy Inc is the notable small-cap position at 100,000 shares valued at roughly $131,000 (about $1.31 per share)
• · Exxon Mobil is listed under the name 'EXXONMOBIL HOLDINGS CORP' in the filing, a naming variant worth noting for data matching

27-10-2026

Armstrong World Industries reported record third-quarter 2026 net sales of $475.8 million, up 11.9% YoY, with operating income up 11.9% to $131.2 million and adjusted EBITDA up 11.0% to $164 million. Diluted EPS rose 9.6% to $2.17 and adjusted diluted EPS rose 10.2% to $2.26. Results were mixed: operating and adjusted EBITDA margins were flat-to-down (adjusted EBITDA margin down 30 bps to 34.5%) under input cost inflation, tariffs and Mineral Fiber mix headwinds, year-to-date operating cash flow fell 10%, and 2026 guidance was updated upward on sales but reflects accelerating cost pressures.

• · Architectural Specialties organic net sales rose $25M, with an $8M inorganic contribution; lower project margins from elevated metal costs partially offset the gain.
• · Mineral Fiber Q3 volume growth was driven primarily by timing-related demand from Canadian customers, a factor the company itself flags as non-recurring in nature.
• · Q3 manufacturing costs rose $10M on input cost inflation (freight and raw materials) and the ongoing tariff impact.
• · Year-to-date operating cash flow declined $23M (10%) on unfavorable receivables timing and higher income tax payments.
• · Year-to-date investing outflows rose $52M, mainly from the Eventscape acquisition cash payment.
• · 2026 guidance raised net sales outlook and reflects accelerating cost pressures and softer contributions from recent acquisitions.
• · Remaining buyback authorization of $1.1B as of September 30, 2026, under a $2.5B program running through December 2029.

27-10-2026

Titan Mining Corporation (TIMCD) furnished a Form 6-K on October 27, 2026, submitting Exhibit 99.1, a press release dated the same day. The cover page identifies the filing as a report of a foreign private issuer for the month of October 2026, and the filing was signed by Purni Parikh, SVP Corporate Affairs and Corporate Secretary. The filing body contains no financial figures, operational metrics, or deal terms; the substantive content resides entirely in the referenced press release, which was not included in the text provided.

• · Filed under Form 40-F multijurisdictional disclosure framework (check mark on Form 40-F), indicating a Canadian-style issuer reporting regime
• · Commission File Number 001-42955
• · Principal executive office listed at 408 Sylvia Lake Rd, Gouverneur, New York 13642
• · Substantive content is contained in Exhibit 99.1 (press release dated October 27, 2026), which was not provided for review